NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ALP Bio AG

ALP Bio AG

Private
SchlierenHealthcare & Life Scienceshttps://alp.bio/

Last Round

Grant

Jul 3, 2026

Total Funding Raised

$2.39M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ALP Bio AG is a biotechnology company developing an immune organoid and AI platform for immunogenicity intelligence in biologics development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Keywords

immunogenicity predictionimmunogenicity risk assessmentanti-drug antibody riskADA riskhuman immune organoidsAI drug discoverydrug de-riskinggenerative AItonsil organoidsorganoid platformcomputational immunologybiobetter designantibody engineeringin silico screeningex vivo validationantibody therapeuticslab-in-the-loopprotein language models

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ALP Bio AG Comps

Public and private peers based on sector, stage, and business model.

ALP Bio AG comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ALP Bio AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 3, 2026
Pre SeedApr 30, 2026

ALP Bio AG Investors

Notable investors and investment history

ALP Bio AG investors
InvestorRounds
42CAPPre Seed
Venture KickGrant, Pre Seed
Ajira VenturesPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2026

    $2.2M round led by 42CAP.

ALP Bio AG Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ALP Bio AG Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ALP Bio AG's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Year Founded2025
Last FundingJul 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.